Cortellis Tackles More Big Data
New solution leverages linked data technologies to power the discovery of new scientific and strategic insights
Thomson Reuters announced the latest addition to its Cortellis suite, an informatics solution for drug discovery and development—Cortellis Data Fusion. Cortellis Data Fusion utilizes linked data technologies—frameworks that allow content to be shared across applications and enterprise or community boundaries—connecting users with data from internal proprietary systems as well as third-party resources to address Big Data challenges.
We last wrote about Cortellis in regards to its Clinical Trials Intelligence analytics tool, which mines data across published trial results in medical publications, internal databases at Thomson and more, to inform clinical trials decisions.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
